ClinicalTrials.Veeva

Menu

Acute Effects of Smoking on Airway Dendritic Cells

U

University of Rostock

Status

Completed

Conditions

Tobacco Use Disorder

Treatments

Behavioral: Smoking

Study type

Interventional

Funder types

Other

Identifiers

NCT00740896
LO-2222

Details and patient eligibility

About

Airway dendritic cells control pulmonary immune responses to inhaled particles. It is the aim of the present study to investigate the acute effects of smoking on the number and surface molecule expression of human airway dendritic cells.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Active smoking (at least 10 cigarettes per day)
  • Age > 18 years

Exclusion criteria

  • Any chronic diseases
  • Any regular medication
  • Any signs or symptoms of an acute infection

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

16 participants in 2 patient groups

1
Active Comparator group
Description:
Participants smoke 8 cigarettes in 4 hours.
Treatment:
Behavioral: Smoking
Behavioral: Smoking
2
Sham Comparator group
Description:
Participants are not allowed to smoke for 4 hours.
Treatment:
Behavioral: Smoking
Behavioral: Smoking

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems